Dr. Susanne Arnold, MD
Claim this profileUniversity of Kentucky/Markey Cancer Center
Expert in Cancer
Expert in Non-Small Cell Lung Cancer
34 reported clinical trials
70 drugs studied
Area of expertise
1Cancer
Global LeaderStage IV
Stage III
KRAS positive
2Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Susanne Arnold, MD is currently running
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
Pembrolizumab + Radiation vs Chemotherapy + Radiation
for Head and Neck Cancer
This phase II trial studies the effect of pembrolizumab alone compared to the usual approach (chemotherapy \[cisplatin and carboplatin\] plus radiation therapy) after surgery in treating patients with head and neck squamous cell carcinoma that has come back (recurrent) or patients with a second head and neck cancer that is not from metastasis (primary). Radiation therapy uses high energy radiation or protons to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. Carboplatin is also in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer and may interfere with the ability of tumor cells to grow and spread. Giving pembrolizumab alone after surgery may work better than the usual approach in shrinking recurrent or primary head and neck squamous cell carcinoma.
Recruiting1 award Phase 231 criteria
More about Susanne Arnold, MD
Clinical Trial Related1 year of experience running clinical trials · Led 34 trials as a Principal Investigator · 23 Active Clinical TrialsTreatments Susanne Arnold, MD has experience with
- Pembrolizumab
- Cisplatin
- Ipatasertib
- Binimetinib
- Paclitaxel
- Carboplatin
Breakdown of trials Susanne Arnold, MD has run
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Recurrence
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Susanne Arnold, MD specialize in?
Susanne Arnold, MD focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are Stage III.
Is Susanne Arnold, MD currently recruiting for clinical trials?
Yes, Susanne Arnold, MD is currently recruiting for 23 clinical trials in Lexington Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Susanne Arnold, MD has studied deeply?
Yes, Susanne Arnold, MD has studied treatments such as Pembrolizumab, Cisplatin, Ipatasertib.
What is the best way to schedule an appointment with Susanne Arnold, MD?
Apply for one of the trials that Susanne Arnold, MD is conducting.
What is the office address of Susanne Arnold, MD?
The office of Susanne Arnold, MD is located at: University of Kentucky/Markey Cancer Center, Lexington, Kentucky 40536 United States. This is the address for their practice at the University of Kentucky/Markey Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.